Double Demonstration of Oncogenic High Risk Human Papilloma Virus DNA and HPV-E7 Protein in Oral Cancers
- 1 April 2011
- journal article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 24 (2_suppl) , 95-101
Abstract
Oncogenic HPVs are necessarily involved in cervical cancer but their role in oral carcinogenesis is debated. To detect HPV in oral cancer, 38 cases of formalin fixed-paraffin embedded OSCC were studied by both DNA genotyping (MY09/11 L1 consensus primers in combination with GP5-GP6 primer pair followed by sequencing) and immunohistochemistry (monoclonal Abs against capsid protein and HPV-E7 protein, K1H8 DAKO and clone 8C9 INVITROGEN, respectively). HPV-16 tonsil cancer was used as positive control. The overall prevalence of HPV infection in OSCCs was 10.5%. Amplification of DNA samples showed single HPV DNA infection in 3 cases (HPV16; HPV53; HPV70) and double infection in one case of cheek cancer (HPV31/HPV44). The overall HR-HPV prevalence was 7.5%. E-7 antigen was immunohistochemically detected in all HPV-positive cases. HPV+ OSCC cases showed an overall better outcome than HPV negative oral cancers, as evaluated by Kaplan-Meier curves. HPVs exert their oncogenic role after DNA integration, gene expression of E5, E6 and E7 loci and p53/pRb host proteins suppression. This study showed that HPV-E7 protein inactivating pRb is expressed in oral cancer cells infected by oncogenic HPV other than classical HR-HPV-16/18. Interestingly HPV-70, considered a low risk virus with no definite collocation in oncogenic type category, gives rise to the expression of HPV-E7 protein and inactivate pRb in oral cancer. HPV-70, as proved in current literature, is able to inactivates also p53 protein, promoting cell immortalization. HPV-53, classified as a possible high risk virus, expresses E7 protein in OSCC, contributing to oral carcinogenesis. We have identified among OSCCs, a subgroup characterized by HPV infection (10.5%). Finally, we have proved the oncogenic potential of some HPV virus types, not well known in literature.Keywords
This publication has 17 references indexed in Scilit:
- Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated reviewHead & Neck Oncology, 2009
- Human Papillomavirus and Head and Neck Squamous Cell Carcinoma: Recent Evidence and Clinical ImplicationsJournal of Dental Research, 2009
- Mechanism of Genomic Instability in Cells Infected with the High-Risk Human PapillomavirusesPLOS Pathogens, 2009
- Oral cancer prevention and control – The approach of the World Health OrganizationOral Oncology, 2009
- Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatmentHead & Neck Oncology, 2009
- Demographic and risk factors in patients with head and neck tumorsJournal of Medical Virology, 2009
- Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity properLaboratory Investigation, 2009
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- E6AP-Dependent Degradation of DLG4/PSD95 by High-Risk Human Papillomavirus Type 18 E6 ProteinJournal of Virology, 2007
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005